Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 3/20 | 0.40 |
| ▸ | HTR2B | P41595 | 3/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 5/20 | 0.39 |
| ▸ | FPR3 | P25089 | 4/20 | 0.38 |
| ▸ | FPR2 | P25090 | 4/20 | 0.38 |
| ▸ | KDM1A | O60341 | 2/20 | 0.38 |
| ▸ | MAOA | P21397 | 2/20 | 0.37 |
| ▸ | MAOB | P27338 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4133946 | 0.94 | CNR1 (0.49) | CNR1GAAHTR2CHTR2BHTR2A | |
| SCHEMBL4133949 | 0.94 | CNR1 (0.49) | CNR1GAAHTR2CHTR2BHTR2A | |
| SCHEMBL4133947 | 0.91 | HTR2C (0.48) | CNR1HTR2CHTR2BDRD2FPR3 | |
| SCHEMBL4133943 | 0.91 | HTR2C (0.48) | CNR1HTR2CHTR2BDRD2FPR3 | |
| SCHEMBL5315451 | 0.89 | HTR2C (0.40) | HTR2CHTR2BHTR2AFPR3FPR2 | |
| SCHEMBL5314514 | 0.88 | BCL2 (0.44) | HTR2CHTR2BFPR3FPR2KDM1A | |
| SCHEMBL5315275 | 0.85 | HTR2C (0.50) | CNR1GAAHTR2CHTR2BHTR2A | |
| SCHEMBL4129089 | 0.84 | HTR2C (0.56) | CNR1GAAHTR2CHTR2BHTR2A | |
| SCHEMBL4129091 | 0.84 | HTR2C (0.56) | CNR1GAAHTR2CHTR2BHTR2A | |
| SCHEMBL4126559 | 0.83 | SLC6A3 (0.44) | GAAHTR2CHTR2BHTR2AKDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007025144-A1 | 5-HT2C RECEPTOR AGONISTS AS ANORECTIC AGENTS | UNIVERSITY OF ILLINOIS - CHICAGO (US) | 2007-03-01 | — | — | WO | disclosed |